In this week’s issue:
- Networks of Centres of Excellence – 2017 NCE International Knowledge Translation Platforms
- BC Innovation Council – BCIC Ignite
- Bill and Melinda Gates Foundation – Grand Challenges Explorations
- American Optometric Foundation – Glaucoma Research Projects
Awards and Honours:
- The Ryman Foundation – The Ryman Prize
- CIHR – Gold Leaf Prizes
- UBC Centre for Blood Research Seminar Series – Dr. Eleanor Fish: Translating discovery to a clinical trial: interferon treatment for Ebola virus disease
- UBC Department of Pathology and Laboratory Medicine – Professional Advancement Learning Series: Consumer Genetics and Microbiome Testing, by Dr. Stephen Yip
- UBC Faculty of Medicine Continuing Professional Development – Family Practice Oncology Network (FPON) Webinar: Thyroid Cancer Diagnosis and Follow-up for Primary Care
- UBC SPARC – NSERC Collaborative Research and Development Grant Workshop
UBC Internal Deadline: April 8, 2016 (see below)
LOI Deadline: May 2, 2016
The goal of the new NCE-IKTP initiative is to support international collaborations between networks, centres, consortia and their partners to accelerate knowledge translation in areas of mutual strategic interest. Proposed networks must be driven to address key problems, challenges or opportunities of high strategic importance for the socio-economic benefit of partners and end users in Canada and abroad. Successful networks will be awarded up to $400,000 per year for four years, with the possibility of a 3-year renewal. A Letter of Intent (LOI), the first step in the competition process is due to NCE by May 2, 2016.
Please note: the NCE-IKTP competition requires presidential support; all support letters will be managed through SPARC. To access SPARC support for your NCE-IKTP please contact Dawn Whitworth (firstname.lastname@example.org) or Helene Dragatsi (Helene.email@example.com) by April 8th 2016.
Please visit the NCE website for additional information.
LOI Deadline: May 2, 2016
BCIC Ignite provides funding to accelerate commercialization of new technologies and innovations in the natural resources and applied sciences in British Columbia. The program provides awards of up to $300,000 to consortia that are conducting research leading to commercializable projects that address a significant demonstrated problem faced by industry.
- Focus: Proposals must involve the areas of natural resources, applied science and/or engineering, and must provide a clearly articulated solution to an existing problem.
- Teams: Applicants must be a BC-based consortium comprised of two or more companies, organizations and academic researchers. All consortia must include an academic member and an industry partner.
- Matching funds: Projects must secure matching funds from industry or government sources at a ratio of 2:1 matching dollars to Ignite dollars.
- Timing: Projects must plan to conclude within 3 years.
- Spring 2016 program, Letter of Intent is due to BCIC by May 2, 2016.
- Summer 2016 program, Letter of Intent is due to BCIC by July 18, 2016
For further information, please visit the BCIC website.
Deadline: May 11, 2016; 11:30am PDT
Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions, is accepting grant proposals until May 11, 2016, 11:30 A.M. US Pacific Day Light Time. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations, and for-profit companies.
Two-page proposals are being accepted online on the following topics:
- Assess Family Planning Needs, Preferences and Behaviors to Inform Innovations in Contraceptive Technologies and Services
- Develop Novel Platforms to Accelerate Contraceptive Drug Discovery
- Design New Analytics Approaches for Malaria Elimination
- Accelerate Development of New Therapies for Childhood Cryptosporidium Infection
- Novel Approaches to Characterizing and Tracking the Global Burden of Antimicrobial Resistance
- Explore New Solutions in Global Health Priority Areas
Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million.
For further information, please visit the Grand Challenges website.
Deadline: July 15, 2016
The American Optometric Foundation, the charitable arm of the American Academy of Optometry, is inviting applications for research projects related to glaucoma and the anterior segment.
Through the Allergan Foundation Research Grant program, a single grant of $60,000 will be awarded to an optometry and vision science faculty member/researcher and up to three co-investigators in the area of glaucoma or the anterior segment. In addition, a $750 travel grant will be provided for the principal investigator and his/her co-investigators on the project to attend the next AAO annual conference. (The recipient(s) must submit a minimum 500-word report of his/her research findings to the AOF at the end of the award period in order to be eligible for subsequent awards sponsored by the Allergan Foundation.)
The award is open to all faculty members and researchers in optometry and vision science.
For complete program guidelines, eligibility criteria, and application instructions, see the AOF website.
AWARDS AND HONOURS:
Nomination Deadline: April 28, 2016
The Ryman Prize is an annual NZ$250,000 award for the world’s best discovery, development, advance or achievement that enhances quality of life for older people. The prize is awarded each year by an international jury appointed by The Ryman Foundation.
The prize, which consists of a cash sum of NZ$250,000 and a commemorative medal, was launched by the Right Honourable John Key, Prime Minister of New Zealand, in February 2015.
The Ryman Prize is an entirely philanthropic initiative. It is independently funded, apolitical and the donor is anonymous.
The winner is selected each year by an international jury appointed by the Ryman Foundation.
The world’s rapidly ageing population means that in some parts of the globe – including most of the Western world – the population aged 75+ is set to triple in the next 30 years.
This large demographic change brings with it some chronic health issues including diabetes and Alzheimer’s disease.
The intention behind the prize is to reward great work done, and also to stimulate fresh thought from the planet’s best minds into this area of need.
Please visit the Ryman Prize website for further information.
Nomination Deadline: September 6, 2016
CIHR has announced its new suite of prizes to celebrate stellar health research achievements. The prizes will be awarded every two years with each prize has a value of $100,000. Winners will also receive a medal.
- CIHR Gold Leaf Prize for Impact
- CIHR Gold Leaf Prize for Discovery
- CIHR Gold Leaf Prize for Outstanding Achievements by an Early Career Investigator
- 2016 CIHR Gold Leaf Prize for Transformation: Patient Engagement
Please visit CIHR’s ResearchNet website for eligibility criteria and nomination instructions.
UBC Centre for Blood Research Seminar Series – Dr. Eleanor Fish: Translating discovery to a clinical trial: interferon treatment for Ebola virus disease
Date & Time: April 6, 2016; 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Eleanor Fish
Professor, Department of Immunology, University of Toronto
Director, Arthritis & Autoimmunity Research Centre, University Health Network
Senior Scientist, Division of Advanced Diagnostics, Toronto General Research Institute
The recent outbreak of Ebola virus disease in West Africa captured international attention, largely because of the magnitude of the outbreak and the high fatality rates. In studies using transcription competent virus-like particles and infectious eGFPEbola virus, we demonstrated that IFN-a/ß limit Ebola virus infection in vitro, and showed that IFN-ß exhibits superior antiviral potency compared with IFN-a. These findings provided the basis for a single arm clinical study to evaluate the safety and efficacy of IFN-ß treatment for Ebola virus disease. The study was undertaken in Coyah, Guinea. IFN-ß treatment facilitated viral clearance from the blood and led to a faster resolution of symptoms associated with disease. Survival, calculated from the date of consent for those in the trial and date of admission from those in the control cohort, to the date of death, was 19% for those receiving supportive care only, compared to 67% for those receiving supportive care plus IFN-ß.
Date & Time: April 8, 2016; 12:30-1:30pm
Location: Eye Care Centre ECC 100, 2550 Willow Street, Vancouver
After attending this PALS session attendees should be able to:
- Understand the technological revolution in genetic profiling that underlies the proliferation of current consumer genomic/microbiomic testings
- Appreciate the current landscape of direct-to-consumer (DTC) genomic testings
- Identify the benefits, risks, and pitfalls of DTC genomic testings
Lunch will be served 15 minutes prior to the session.
Pls note, absolutely no food or drink is allowed in the ECC auditorium.
We will not be providing water/juice – pls remember to bring your own, and come on time to lunch, as you will not be permitted to bring anything into the auditorium.
*Video conferencing available at UBC LSC1312, SPH 4/5 and BCCH CSB V2-222 (please email me for attending through VC)
* Audio Bridge: ID 30229 (1-877-792-2768)
- Please note, this is a mandatory course for all Pathology PGY2-5 residents. If you cannot attend, please notify our office in writing.
- Note for Radiology and ID managers: please feel free to forward this invite to your residents.
- Faculty, Graduate Students and others are also welcome to attend.
- Notes about credit evaluation: for Faculty, Graduate Students, Fellows and others, the Credit Evaluation Form is available from the UBC Pathology PALS website for credit purpose or providing feedback. All the evaluations will be provided to the presenter(s) anonymously.
For more information on upcoming events, please visit UBC Pathology PALS Website.
Date & Time: April 21, 2016; 8-9am PST
Target Audience: GPOs and all other cancer care providers
Accreditation: up to 1.0 Mainpro-M1 credits
Presented by Dr. Jonn Wu, BC Cancer Agency Vancouver Centre
Please register at http://ubccpd.ca/course/FPON-webinar-thyroid-cancer-2016.
Date & Time: May 5, 2016; 1-3pm
Location: Room 101, Michael Smith Laboratories, 2185 East Mall, Vancouver
SPARC is once again organizing an NSERC Collaborative Research and Development Grant (CRD) workshop for UBC researchers interested in applying to this significant research partnership funding program. This information session will be aimed at providing potential applicants with important information on how to submit an impactful and successful CRD application.
Pamela Moss, Director (MCT Division), Research Partnerships, from the NSERC-Ottawa office will be visiting UBC (Vancouver campus) to make a presentation on CRDs and meet with researchers, and answer any questions related to the NSERC CRD program.
Please visit the SPARC website to register.
If you have any questions or concerns, please feel free to contact: David Woods (firstname.lastname@example.org).